Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boland

Showing results (521-530 of 571) with videos related to

Pageof 58
Sort By:
Nature Medicine|May 9, 2024
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisMolly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
The British Journal of Dermatology|March 16, 2022
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational studyXue Bai, Alexander N Shoushtari, Allison Betof Warner, et al.
Animal Frontiers : the Review Magazine of Animal Agriculture|October 22, 2021
Taking the steps toward sustainable livestock: our multidisciplinary global farm platform journeyM Jordana Rivero, Alex C O Evans, Alexandre Berndt, et al.
Cancer Discovery|April 8, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and ImmunityIsabella C Glitza, Yongwoo David Seo, Christine N Spencer, et al.
Nature Communications|September 15, 2023
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironmentYufeng Wang, David L Drum, Ruochuan Sun, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Journal for Immunotherapy of Cancer|September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancerLeyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Journal of Dairy Science|April 23, 2018
Symposium review: Uncertainties in enteric methane inventories, measurement techniques, and prediction modelsA N Hristov, E Kebreab, M Niu, et al.
Nature Cancer|January 23, 2023
Fucosylation of HLA-DRB1 regulates CD4<sup>+</sup> T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacyDaniel K Lester, Chase Burton, Alycia Gardner, et al.
Pageof 58

Showing results (521-530 of 571) with videos related to

Sort By:
Pageof 58
Nature Medicine|May 9, 2024
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitisMolly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, et al.
Cancer Discovery|November 18, 2020
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses FerroptosisXin Hong, Whijae Roh, Ryan J Sullivan, et al.
The British Journal of Dermatology|March 16, 2022
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational studyXue Bai, Alexander N Shoushtari, Allison Betof Warner, et al.
Animal Frontiers : the Review Magazine of Animal Agriculture|October 22, 2021
Taking the steps toward sustainable livestock: our multidisciplinary global farm platform journeyM Jordana Rivero, Alex C O Evans, Alexandre Berndt, et al.
Cancer Discovery|April 8, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and ImmunityIsabella C Glitza, Yongwoo David Seo, Christine N Spencer, et al.
Nature Communications|September 15, 2023
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironmentYufeng Wang, David L Drum, Ruochuan Sun, et al.
Research Square|September 2, 2025
Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of toleranceKoki Hayashi, Takahiro Yokose, Jenna Lancey, et al.
Journal for Immunotherapy of Cancer|September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancerLeyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Journal of Dairy Science|April 23, 2018
Symposium review: Uncertainties in enteric methane inventories, measurement techniques, and prediction modelsA N Hristov, E Kebreab, M Niu, et al.
Nature Cancer|January 23, 2023
Fucosylation of HLA-DRB1 regulates CD4<sup>+</sup> T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacyDaniel K Lester, Chase Burton, Alycia Gardner, et al.
Pageof 58